ArticleDie Ophthalmologie2026
[C-Quant scattered light measurement and corneal densitometry in Fuchs endothelial dystrophy before and after DMEK].
Article in Die Ophthalmologie, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundIn Germany, each surgical corneal center defines individual criteria for the indications for Descemet membrane endothelial keratoplasty (DMEK). Clinical experience shows a clear discrepancy between best corrected visual activity (BCVA) and subjective complaints, such as increased sensitivity to glare. Increasing symptoms with apparently stable visual acuity suggest that BCVA alone is not sufficient to adequately capture the overall visual impairment. The aim of this study is therefore to make subjective complaints, in particular the perceived scattered light, measurable by means of quantitative parameters and to analyze their progression preoperatively and postoperatively in the context of DMEK longitudinally and to evaluate the extent to which ocular forward scattered light can determine the optimal time for surgical intervention. PATIENTS AND
methodsThis retrospective study included 149 patients with Fuchs endothelial corneal dystrophy (FECD) who underwent DMEK or triple DMEK surgery at the Saarland University Hospital Medical Center between 2018 and 2020. The prerequisite for participation was the availability of complete preoperative and postoperative measurement data after 6 weeks and 6 months. All patients underwent BCVA, central corneal thickness (CCT), corneal densitometry (backward scattered light) using Pentacam and ocular forward scattered light using C‑Quant.
resultsThe ocular forward scattered light showed a significant improvement comparing the preoperative and 6‑month values; however, ocular forward scattered light did not correlate with BCVA or CCT at time. The CCT and backward scattered light decreased significantly after 6 weeks and remained stable in the further course. The BCVA significantly improved after 6 weeks postoperatively. There was a significant correlation between ocular forward scattered light and backward scattered light at all measurement times. Additionally, there were significant positive correlations between preoperative backward scattered light and both CCT and BCVA.
conclusionThe measurement of ocular forward scattered light via C‑Quant alone has not proven to be a reliable criterion for determining the indications for DMEK or triple DMEK; however, both surgical procedures led to a sustained reduction in CCT and backward scattered light (densitometry) as well as a significant improvement in BCVA.
Indexed as
Identifiers
41870611What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.